Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey

Endocrinology

Volumn 143, Issue 7, 2002, Pages 2496-2502

  Zimmermann, Ralf C ^a   Xiao, Ennian ^a   Bohlen, Peter ^b   Ferin, Michel ^a  

^a Columbia University ^*  (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; PROGESTERONE; RECEPTOR ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; EVALUATION; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HORMONE ACTION; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RHESUS MONKEY;

EID: 0036284145     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.7.8896     Document Type: Article

References (31)

1. Angiogenesis in reproductive tissues
2. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc [vascular endothelial growth factor Trap(A40)]
3. The ovarian triad of the primate menstrual cycle
4. Follicle-stimulating hormone enhances the development of preantral follicles in juvenile rats
5. Angiogenesis and vascular regression in the ovary
6. Gonadotropin-binding sites in the rhesus monkey ovary: Role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle
7. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
8. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey
9. Role of vascular endothelial growth factor in ovarian physiology and pathology
10. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary
11. Monoclonal antibody strategies to block angiogenesis
12. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells
13. Inhibition of ovarian angiogenesis by a VEGF receptor 2 antibody blocks gonadotropin mediated development of mature antral follicles
14. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles
15. Monoclonal antibodies targeting the VEGF receptor-2 (F1k1/KDR) as an anti-angiogenic therapeutic strategy
16. Measurement of dimeric inhibin B throughout the human menstrual cycle
17. Inhibin-B in the male rhesus monkey: Impact of neonatal gonadotropin-releasing hormone antagonist treatment and sexual development
18. Preparation of monoclonal antibodies to the βA subunit of ovarian inhibin using a synthetic peptide immumogen
19. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay
20. Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol
21. Follicle-stimulating hormone-inhibin B interactions during the follicular phase the primate menstrual cycle revealed by gonadotropin-releasing hormone antagonist and antiestrogen treatment
22. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: Duration, rather than magnitude, of FSH increase affects follicle development
23. Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: Expression is independent of hypothalamic control
24. Luteal angiogenesis: Prevention and intervention by treatment with vascular endothelial growth factor trap(A40)
25. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea
26. Follicle selection in primates: "many are called but few are chosen"
27. Passive immunization with anti-oestradiol antibodies during the luteal phase of the menstrual cycle potentiates the perimenstrual rise in serum gonadotrophin concentrations and stimulates follicular growth in the cynomolgus monkey (Macaca fascicularis)
28. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent
29. Identification of an angiogenic mitogen selective for endocrine gland endothelium
30. Stress and the menstrual cycle: Relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey
31. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel